These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 8977542)

  • 1. Clinical comparison of histamine H1-receptor antagonist drugs.
    Du Buske LM
    J Allergy Clin Immunol; 1996 Dec; 98(6 Pt 3):S307-18. PubMed ID: 8977542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of H1-antihistamines: an update.
    Kalpaklioglu F; Baccioglu A
    Antiinflamm Antiallergy Agents Med Chem; 2012; 11(3):230-7. PubMed ID: 23173575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsedating antihistamines: pharmacology, clinical efficacy and adverse effects.
    Kaliner MA
    Am Fam Physician; 1992 Mar; 45(3):1337-42. PubMed ID: 1347437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H1-antihistamines in the elderly.
    Kaliner MA
    Clin Allergy Immunol; 2002; 17():465-81. PubMed ID: 12113227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cetirizine: antiallergic therapy beyond traditional H1 antihistamines.
    Sheffer AL; Samuels LL
    J Allergy Clin Immunol; 1990 Dec; 86(6 Pt 2):1040-6. PubMed ID: 1979800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oral second generation antihistamines in allergic rhinitis].
    Riechelmann H
    Laryngorhinootologie; 2005 Jan; 84(1):30-41. PubMed ID: 15647976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological management of allergic rhinitis in the elderly: safety issues with oral antihistamines.
    Hansen J; Klimek L; Hörmann K
    Drugs Aging; 2005; 22(4):289-96. PubMed ID: 15839718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsedating histamine H1-receptor antagonists.
    Mann KV; Crowe JP; Tietze KJ
    Clin Pharm; 1989 May; 8(5):331-44. PubMed ID: 2568212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of the central nervous system adverse effects associated with antihistamines in the management of allergic disorders: strategies and progress.
    Gengo FM
    J Allergy Clin Immunol; 1996 Dec; 98(6 Pt 3):S319-25. PubMed ID: 8977543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiallergic anti-inflammatory effects of H1-antihistamines in humans.
    Assanasen P; Naclerio RM
    Clin Allergy Immunol; 2002; 17():101-39. PubMed ID: 12113215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appraisal of the validity of histamine-induced wheal and flare to predict the clinical efficacy of antihistamines.
    Monroe EW; Daly AF; Shalhoub RF
    J Allergy Clin Immunol; 1997 Feb; 99(2):S798-806. PubMed ID: 9042073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pharmacology of second-generation antihistamines.
    Grant JA
    Allergy Asthma Proc; 2000; 21(3):135-40. PubMed ID: 10892514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H1-antihistamines and the central nervous system.
    Welch MJ; Meltzer EO; Simons FE
    Clin Allergy Immunol; 2002; 17():337-88. PubMed ID: 12113223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders.
    Wiseman LR; Faulds D
    Drugs; 1996 Feb; 51(2):260-77. PubMed ID: 8808167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-generation H1-receptor antagonists.
    Simons FE; Simons KJ
    Ann Allergy; 1991 Jan; 66(1):5-16, 19. PubMed ID: 1670985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of H1-receptor antagonist treatment.
    Simons FE
    Ann Allergy; 1993 Sep; 71(3):282-7. PubMed ID: 8103973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects.
    Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW
    Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second-generation antihistamines: actions and efficacy in the management of allergic disorders.
    Golightly LK; Greos LS
    Drugs; 2005; 65(3):341-84. PubMed ID: 15669879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety considerations in the management of allergic diseases: focus on antihistamines.
    Yanai K; Rogala B; Chugh K; Paraskakis E; Pampura AN; Boev R
    Curr Med Res Opin; 2012 Apr; 28(4):623-42. PubMed ID: 22455874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rupatadine: global safety evaluation in allergic rhinitis and urticaria.
    González-Núñez V; Bachert C; Mullol J
    Expert Opin Drug Saf; 2016 Oct; 15(10):1439-48. PubMed ID: 27500993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.